India Plans New Clinical Trial Laws
This article was originally published in The Pink Sheet Daily
Executive Summary
Current voluntary human subjects guidelines will be revised after the death of an infant in a pneumococcal vaccine trial.
You may also be interested in...
U.S. FDA Readies India Staffing; Says India Office To Enhance Speed And Effectiveness Of Regulatory Cooperation
MUMBAI - U.S. FDA has hand picked a few top notch professionals from its global headquarters for positions at the newly planned Mumbai and New Delhi offices. Over the years, these officers have gained experience in drug regulation and investigations through several global postings
List Ahead For Southeast Asia Pharma In 2015
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.
Southeast Asia 2014: Distribution, Manufacturing To The Fore
Southeast Asia in 2014 saw a continued push by several nations in the region to ink a Trans-Pacific Partnership pact that would potentially have a major impact on biological drugs. Also manufacturing and distribution saw a leap in the hub of Singapore as governments in the region ramped-up health spending.